ASML's Monopoly Has a 30% Problem

ASML's position in the semiconductor supply chain is genuinely unusual. Most technology moats are durable but contestable: a competitor with enough capital and talent can eventually replicate a cloud platform, a search engine, or an operating system. EUV lithography is different.

The machines cost approximately 380 million euros each. They contain over 100,000 components sourced from a global network of suppliers that has taken three decades to assemble. The light source, produced by a laser striking a tin droplet 50,000 times per second at a specific pulse rate, creates plasma that emits extreme ultraviolet light at 13.5 nanometers. The entire optical system must maintain tolerances measured in fractions of a nanometer while the machine operates in a near-vacuum.

China has been trying to develop a domestic equivalent for years. Its efforts have not come close. The ASML monopoly on EUV is not a matter of intellectual property or regulatory protection. It is a matter of physics, precision manufacturing, and supply chain depth that cannot be replicated on a policy timeline.

ASML also produces deep ultraviolet (DUV) systems, which use older technology to manufacture chips at larger nodes. These machines are not unique: Nikon and Canon produce competing equipment. But DUV still accounts for the majority of ASML's unit volume, and it is DUV that China currently buys in large quantities.

Revenue grew from 18.6 billion euros in 2021 to 32.7 billion euros in 2025, a compound annual growth rate of approximately 15%. Operating margins moved from 36.3% in 2021, compressed to 30.7% in 2022 as the company scaled manufacturing, and recovered to 34.6% in 2025. Net income reached 9.6 billion euros in 2025, up from 5.9 billion in 2021.

Those are strong numbers. But the margin trajectory reveals something important: operating leverage at ASML is real but not aggressive. Gross margins have held in the 51-53% range across the full period, barely moving despite significant revenue growth. The operating margin improvement in 2025 reflects volume absorption rather than structural margin expansion.

The free cash flow picture is more volatile. FCF was 9.9 billion euros in 2021, collapsed to 3.2 billion in 2023 as the company invested heavily in capacity, then recovered to 10.6 billion in 2025. The 2023 trough matters because it coincided with peak capex investment at a moment when Chinese customers were loading up on DUV machines ahead of anticipated restrictions. That pulled demand forward, which partly explains why the 2024 and 2025 revenue growth looks modest relative to the previous cycle.

The EUV monopoly is the most discussed aspect of ASML's competitive position, but the more operationally important point is the installed base. ASML has shipped over 200 EUV machines to date. Each machine requires ongoing service, parts, and software upgrades. The service revenue stream is growing faster than equipment revenue and carries higher margins.

This creates a recurring revenue dynamic that does not exist in most capital equipment businesses. Once a chipmaker installs ASML EUV systems, switching costs are not just financial. The entire fab process is designed around the machine's specific optical characteristics, overlay accuracy, and throughput specs. Replacing installed ASML equipment with a hypothetical competitor would require requalifying every layer of the manufacturing process. No one would do it.

The DUV installed base has a similar but weaker dynamic. Nikon and Canon do compete in DUV. They have done so for decades. ASML's DUV market share is dominant but not absolute, and the competitive pressure on DUV pricing is real. This matters because if DUV export restrictions expand, ASML does not just lose volume. It loses volume in a product segment where it does not have EUV-level pricing power.

ASML generated 10.6 billion euros of free cash flow in 2025, up from 9.5 billion in 2024 and dramatically above the 3.2 billion trough in 2023. The company returned 5.7 billion euros to shareholders via buybacks in 2025, the most aggressive repurchase program in at least five years.

The timing of that acceleration is notable. ASML bought back significant stock in 2021 at prices that now look prescient, then stepped back from buybacks in 2022 and 2023 as the stock climbed and capex demands absorbed cash. The 2025 buyback surge came as the stock sold off from its 2024 peak, suggesting management views the current price as a reasonable entry point for repurchases.

The balance sheet is clean. Net cash stands at approximately 10.2 billion euros, with 12.9 billion in cash against 2.7 billion of total debt. ASML has the financial capacity to sustain buybacks and dividends through a two-year demand pause if restrictions materialize. The question is not solvency. It is whether the growth trajectory that justifies 46 times earnings survives a China revenue reset.

ASML trades at 46 times trailing earnings and 35.8 times EV/EBITDA. On price-to-sales, the stock is at 15.8 times. These are not screaming-overvalued numbers for a monopoly with 34% operating margins and 10 billion euros of annual free cash flow. But they are not forgiving numbers either.

At current multiples, the market is pricing in sustained double-digit earnings growth for at least the next seven to ten years. The bull case that supports that growth requires AI infrastructure spending to remain at or above current levels, TSMC and Samsung to continue their capacity expansion programs, and the China revenue base to either hold steady or be replaced quickly by other customers.

Analyst consensus remains constructive: 22 strong buy ratings, 8 buy ratings, and only 1 strong sell against a price target of 1,475 dollars. That target implies meaningful upside from current levels. But consensus targets are set against a forward earnings estimate that was built before the April 2026 export restriction legislative push. If 30% of revenue faces material risk, the forward multiple expands, and the target comes down.

Sentiment over the past 30 days has been broadly positive, with normalized sentiment scores between 0.65 and 0.99 on most days. The April 3 news day is the first meaningful exception, with one article on US export restriction targeting pulling sentiment toward negative territory. That divergence between high institutional ownership enthusiasm and the emerging legislative risk is worth tracking.